Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Autor: E, Hommel, B, Olsen, T, Battelino, I, Conget, I, Schütz-Fuhrmann, R, Hoogma, U, Schierloh, N, Sulli, H, Gough, J, Castañeda, S, de Portu, J, Bolinder, B, Shashaj
Rok vydání: 2014
Předmět:
Blood Glucose
Male
medical resources
Endocrinology
Diabetes and Metabolism

treatment satisfaction
insulin pump therapy
law.invention
Indirect costs
Endocrinology
Quality of life
Randomized controlled trial
law
Medicine
Insulin
Young adult
Child
Continuous glucose monitoring
Multidisciplinary
general & others [D99] [Human health sciences]

Cross-Over Studies
Incidence (epidemiology)
Medicine (all)
Hemoglobin A
General Medicine
Health Care Costs
Middle Aged
Diabetes and Metabolism
Patient Satisfaction
Original Article
Type 1
Medical resources
Adult
medicine.medical_specialty
Multidisciplinaire
généralités & autres [D99] [Sciences de la santé humaine]

Adolescent
sensouraugmented insulin pump therapy
Glycosylated
Young Adult
Insulin pump therapy
Patient satisfaction
Insulin Infusion Systems
Diabetes Mellitus
Internal Medicine
Humans
Hypoglycemic Agents
Aged
Glycated Hemoglobin
Type 1 diabetes
Treatment satisfaction
business.industry
Blood Glucose Self-Monitoring
Sensor-augmented insulin pump therapy
Diabetes Mellitus
Type 1

Hemoglobin A
Glycosylated

Quality of Life
medicine.disease
Crossover study
Surgery
quality of life
Physical therapy
business
Zdroj: Acta Diabetologica
Acta Diabetologica, 51(5), 845-851. Berlin, Germany: Springer Verlag (2014).
ISSN: 1432-5233
Popis: To investigate the impact of continuous glucose monitoring (CGM) on health-related quality of life (HRQOL), treatment satisfaction (TS) medical resource use, and indirect costs in the SWITCH study. SWITCH was a multicentre, randomized, crossover study. Patients with type 1 diabetes (n = 153) using continuous subcutaneous insulin infusion (CSII) were randomized to a 12 month sensor-On/Off or sensor-Off/On sequence (6 months each treatment), with a 4-month washout between periods. HRQOL in children and TS in adults were measured using validated questionnaires. Medical resource utilization data were collected. In adults, TS was significantly higher in the sensor-On arm, and there were significant improvements in ratings for treatment convenience and flexibility. There were no clinically significant differences in children’s HRQOL or parents’ proxy ratings. The incidence of severe hypoglycaemia, unscheduled visits, or diabetes-related hospitalizations did not differ significantly between the two arms. Adult patients made fewer telephone consultations during the sensor-On arm; children’s caregivers made similar numbers of telephone consultations during both arms, and calls were on average only 3 min longer during the sensor-On arm. Regarding indirect costs, children with >70 % sensor usage missed fewer school days, compared with the sensor-Off arm (P = 0.0046) but there was no significant difference in the adults days of work off. The addition of CGM to CSII resulted in better metabolic control without imposing an additional burden on the patient or increased medical resource use, and offered the potential for cost offsets.
Databáze: OpenAIRE